|
Age (years)
|
61.8 (25.0)
|
65.0 (15.5)
|
59.5 (29.9)
|
0.019
|
|
Male, %
|
314 (67.4%)
|
111 (56.6%)
|
203 (75.2%)
|
< 0.001
|
|
Diabetes,%
|
118 (25.3%)
|
51 (26.0%)
|
67 (24.8%)
|
0.768
|
|
Hypertension, %
|
244 (52.4%)
|
97 (49.5%)
|
147 (54.4%)
|
0.290
|
|
Ischemic heart failure, %
|
125 (26.8%)
|
53 (27.0%)
|
72 (26.7%)
|
0.928
|
|
NYHA
| | | |
0.041
|
|
II
|
57 (21.1%)
|
24 (12.2%)
|
81 (17.4%)
| |
|
III
|
138 (51.1%)
|
108 (55.1%)
|
246 (52.8%)
| |
|
IV
|
75 (27.8%)
|
64 (32.7%)
|
139 (29.8%)
| |
|
Heart rate, beats/min
|
85.5 (20.9)
|
85.1 (21.4)
|
85.7 (20.6)
|
0.731
|
|
Systolic blood pressure (mmHg)
|
127 (22.6)
|
124 (19.9)
|
129 (24.2)
|
0.020
|
|
Diastolic blood pressure (mmHg)
|
78.5 (15.2)
|
76.0 (12.2)
|
80.4 (16.8)
|
0.002
|
|
Potassium (mmol/L)
|
3.99 (0.51)
|
3.99 (0.51)
|
3.99 (0.50)
|
0.912
|
|
Sodium (mmol/L)
|
140 (3.9)
|
139 (4.2)
|
140 (3.7)
|
0.086
|
|
Albumin (g/L)
|
3.66 (0.48)
|
3.60 (0.49)
|
3.71 (0.47)
|
0.025
|
|
Creatinine (mg/dL)
|
1.16 (0.65)
|
1.21 (0.61)
|
1.12 (0.68)
|
0.131
|
|
Uric acid (mg/dL)
|
8.13 (2.83)
|
8.41(3.06)
|
7.93 (2.64)
|
0.070
|
|
ALT (U/L)
|
27(17–46)
|
26(15–50)
|
27(18–44)
|
0.550
|
|
AST (U/L)
|
28(22–42)
|
28(22–48)
|
28(22–39)
|
0.162
|
|
INR
|
1.20 (0.28)
|
1.22 (0.26)
|
1.18 (0.30)
|
0.142
|
|
Total bilirubin (mg/dL)
|
1.23 (1.03)
|
1.28 (1.00)
|
1.19 (1.04)
|
0.348
|
|
proBNP (ng/L)
|
2254 (1269–5835)
|
2873 (1572–7373)
|
1779 (1087–4601)
|
< 0.001
|
|
CRP (mg/L)
|
2.9 (1.2 –6.7)
|
3.1 (1.2 –7.5)
|
2.7 (1.0 –6.5)
|
0.125
|
|
Anemia, %
|
133 (28.5)
|
64 (32.5%)
|
69 (25.6%)
|
0.073
|
|
LVEF (%)
|
41.6 (14.4)
|
39.8 (13.8)
|
44.0 (14.9)
|
< 0.001
|
|
Pulmonary hypertension, %
|
117 (25.1%)
|
65 (33.2%)
|
52 (19.3%)
|
0.001
|
|
Tricuspid regurgitation, %
| | | |
0.004
|
|
No
|
43 (9.2%)
|
17 (8.7%)
|
26 (9.6%)
| |
|
Mild
|
197 (42.3%)
|
70 (35.7%)
|
127 (47.0%)
| |
|
Moderate
|
139 (29.8%)
|
57 (29.1%)
|
82 (30.4%)
| |
|
Severe
|
87 (18.7%)
|
52 (26.5%)
|
35 (13.0%)
| |
|
RVDd (mm)
|
39.8 (8.21)
|
40.3 (8.94)
|
39.4 (7.63)
| |
|
Body mass index (kg/M2)
|
24.2 (5.7)
|
23.6 (5.7)
|
24.6 (5.8)
|
0.068
|
|
Antisterone, %
|
415 (89.1%)
|
177 (90.3%)
|
238 (88.1%)
|
0.451
|
|
ACEI/ARB, %
|
365 (78.3%)
|
151 (77.0%)
|
214 (79.3%)
|
0.566
|
|
Beta-blocker, %
|
373 (80.0%)
|
151 (77.0%)
|
222 (82.2%)
|
0.167
|
|
Aspirin, %
|
198 (42.5%)
|
85 (43.4%)
|
113 (41.9%)
|
0.744
|
|
MELD
|
8.5 (7.2–10.9)
|
8.9 (7.4–11.9)
|
8.3 (7.1–10.2)
|
0.004
|
|
MELD_XI
|
11.3 (9.4–13.8)
|
11.8 (9.4–15.2)
|
11.0 (9.4–13.2)
|
0.008
|
|
MELD_sodium
|
8.6 (6.5–12.4)
|
9.4 (6.9–14.0)
|
8.3 (6.3–11.0)
|
0.004
|
|
MELD_albumin
|
12.3 (9.6–15.2)
|
13.1 (10.6–16.4)
|
11.6 (9.0–14.6)
|
< 0.001
|
